Youth vaping and smoking and parental vaping: a panel survey.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
28 Jul 2020
Historique:
received: 15 01 2020
accepted: 08 07 2020
entrez: 29 7 2020
pubmed: 29 7 2020
medline: 28 11 2020
Statut: epublish

Résumé

Concerns remain about potential negative impacts of e-cigarettes including possibilities that: youth e-cigarette use (vaping) increases risk of youth smoking; and vaping by parents may have impacts on their children's vaping and smoking behaviour. With panel data from 3291 youth aged 10-15 years from the 7th wave of the UK Understanding Society Survey (2015-2017), we estimated effects of youth vaping on youth smoking (ever, current and past year initiation), and of parental vaping on youth smoking and vaping, and examined whether the latter differed by parental smoking status. Propensity weighting was used to adjust for measured confounders and estimate average effects of vaping for all youth, and among youth who vaped. E-values were calculated to assess the strength of unmeasured confounding influences needed to negate our estimates. Associations between youth vaping and youth smoking were attenuated considerably by adjustment for measured confounders. Estimated average effects of youth vaping on youth smoking were stronger for all youth (e.g. OR for smoking initiation: 32.5; 95% CI: 9.8-107.1) than among youth who vaped (OR: 4.4; 0.6-30.9). Relatively strong unmeasured confounding would be needed to explain these effects. Associations between parental vaping and youth vaping were explained by measured confounders. Estimates indicated effects of parental vaping on youth smoking, especially for youth with ex-smoking parents (e.g. OR for smoking initiation: 11.3; 2.7-46.4) rather than youth with currently smoking parents (OR: 1.0; 0.2-6.4), but these could be explained by relatively weak unmeasured confounding. While measured confounding accounted for much of the associations between youth vaping and youth smoking, indicating support for underlying propensities, our estimates suggested residual effects that could only be explained away by considerable unmeasured confounding or by smoking leading to vaping. Estimated effects of youth vaping on youth smoking were stronger among the general youth population than among the small group of youth who actually vaped. Associations of parental vaping with youth smoking and vaping were either explained by measured confounding or could be relatively easily explained by unmeasured confounding.

Sections du résumé

BACKGROUND BACKGROUND
Concerns remain about potential negative impacts of e-cigarettes including possibilities that: youth e-cigarette use (vaping) increases risk of youth smoking; and vaping by parents may have impacts on their children's vaping and smoking behaviour.
METHODS METHODS
With panel data from 3291 youth aged 10-15 years from the 7th wave of the UK Understanding Society Survey (2015-2017), we estimated effects of youth vaping on youth smoking (ever, current and past year initiation), and of parental vaping on youth smoking and vaping, and examined whether the latter differed by parental smoking status. Propensity weighting was used to adjust for measured confounders and estimate average effects of vaping for all youth, and among youth who vaped. E-values were calculated to assess the strength of unmeasured confounding influences needed to negate our estimates.
RESULTS RESULTS
Associations between youth vaping and youth smoking were attenuated considerably by adjustment for measured confounders. Estimated average effects of youth vaping on youth smoking were stronger for all youth (e.g. OR for smoking initiation: 32.5; 95% CI: 9.8-107.1) than among youth who vaped (OR: 4.4; 0.6-30.9). Relatively strong unmeasured confounding would be needed to explain these effects. Associations between parental vaping and youth vaping were explained by measured confounders. Estimates indicated effects of parental vaping on youth smoking, especially for youth with ex-smoking parents (e.g. OR for smoking initiation: 11.3; 2.7-46.4) rather than youth with currently smoking parents (OR: 1.0; 0.2-6.4), but these could be explained by relatively weak unmeasured confounding.
CONCLUSIONS CONCLUSIONS
While measured confounding accounted for much of the associations between youth vaping and youth smoking, indicating support for underlying propensities, our estimates suggested residual effects that could only be explained away by considerable unmeasured confounding or by smoking leading to vaping. Estimated effects of youth vaping on youth smoking were stronger among the general youth population than among the small group of youth who actually vaped. Associations of parental vaping with youth smoking and vaping were either explained by measured confounding or could be relatively easily explained by unmeasured confounding.

Identifiants

pubmed: 32718309
doi: 10.1186/s12889-020-09228-w
pii: 10.1186/s12889-020-09228-w
pmc: PMC7385857
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1111

Subventions

Organisme : Chief Scientist Office
ID : SPHSU12
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12017/13
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU13
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU17
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12017/12
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00022/2
Pays : United Kingdom

Références

Tob Control. 2017 Aug 17;:
pubmed: 28818839
Am J Public Health. 2016 Apr;106(4):672-8
pubmed: 26794178
Am J Epidemiol. 2018 Nov 1;187(11):2397-2404
pubmed: 29955810
JAMA. 2015 Aug 18;314(7):700-7
pubmed: 26284721
Eur J Epidemiol. 2018 Mar;33(3):323-334
pubmed: 29260431
J Health Econ. 2015 Dec;44:300-8
pubmed: 26583343
Int J Environ Res Public Health. 2019 Aug 26;16(17):
pubmed: 31455009
Addiction. 2014 Nov;109(11):1801-10
pubmed: 25078252
BMC Public Health. 2015 Mar 31;15:244
pubmed: 25886064
Addiction. 2020 Mar;115(3):507-517
pubmed: 31597207
Biometrics. 2012 Mar;68(1):129-37
pubmed: 22050039
Pediatrics. 2016 Jul;138(1):
pubmed: 27296866
Nicotine Tob Res. 2015 Oct;17(10):1187-94
pubmed: 25896067
Nicotine Tob Res. 2015 Jul;17(7):810-8
pubmed: 25385873
Health Educ Behav. 2019 Apr;46(2):275-285
pubmed: 30606077
Tob Control. 2017 Aug 4;:
pubmed: 28778971
J Psychiatr Res. 2014 Jul;54:43-54
pubmed: 24680203
J Adolesc Health. 2018 May;62(5):539-547
pubmed: 29499983
JAMA Pediatr. 2017 Aug 1;171(8):788-797
pubmed: 28654986
Addiction. 2018 Mar;113(3):391-404
pubmed: 28975720
Tob Control. 2017 Jul 22;:
pubmed: 28735273
J Adolesc Health. 2013 Feb;52(2):135-6
pubmed: 23332475
Ann Intern Med. 2017 Mar 21;166(6):390-400
pubmed: 28166548
Nicotine Tob Res. 2016 May;18(5):647-53
pubmed: 26386472
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Soc Sci Med. 2014 Oct;119:45-52
pubmed: 25150650
Annu Rev Public Health. 2018 Apr 1;39:193-213
pubmed: 29323611
JAMA. 2016 Nov 8;316(18):1918-1920
pubmed: 27825000
Tob Control. 2020 Mar;29(2):207-216
pubmed: 30936390
BMJ. 2016 Sep 13;354:i4645
pubmed: 27624188
Am J Public Health. 2020 Feb;110(2):161-162
pubmed: 31913680
Addiction. 2018 Oct;113(10):1776-1783
pubmed: 28786147
N Engl J Med. 2014 Sep 4;371(10):932-43
pubmed: 25184865
BMJ Open. 2016 Nov 16;6(11):e013271
pubmed: 27852721
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
Stat Med. 2015 Dec 10;34(28):3661-79
pubmed: 26238958
Ann Intern Med. 2017 Aug 15;167(4):268-274
pubmed: 28693043
Addiction. 2018 Mar;113(3):405-406
pubmed: 29152810
JAMA Pediatr. 2014 Jul;168(7):610-7
pubmed: 24604023
Tob Control. 1998 Winter;7(4):409-20
pubmed: 10093176

Auteurs

Michael J Green (MJ)

MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, 200 Renfield Street, Glasgow, G2 3AX, UK. michael.green@glasgow.ac.uk.

Linsay Gray (L)

MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, 200 Renfield Street, Glasgow, G2 3AX, UK.

Helen Sweeting (H)

MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, 200 Renfield Street, Glasgow, G2 3AX, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH